Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Other Working Capital Changes (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Other Working Capital Changes for 2 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 307.01% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.3 million, a N/A change, with the full-year FY2024 number at $95000.0, down 90.48% from a year prior.
  • Other Working Capital Changes was $2.0 million for Q3 2025 at Pyxis Oncology, up from -$362000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.0 million in Q3 2025 to a low of -$970000.0 in Q3 2024.